Full text is available at the source.
Abstract
IL7R mRNA therapy may enhance antitumor immunity and improve tumor control.
- Interleukin-7 receptor (IL7R) signaling is essential for T-cell survival and immune function.
- Increasing IL7R expression through mRNA delivery could be a potential therapeutic strategy.
- The effectiveness of IL7R mRNA therapy was examined in preclinical cancer models.
Simplified